MSPD: Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer

Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle (Other)
Overall Status
Recruiting
CT.gov ID
NCT05315427
Collaborator
(none)
40
1
12
3.3

Study Details

Study Description

Brief Summary

The aim of this study is to assess the impact of music therapy on the pain of patients cared at the Montpellier Cancer Institute (ICM) for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

Condition or Disease Intervention/Treatment Phase
  • Other: one music therapy session

Detailed Description

Music therapy is a care practice that falls within the field of support, help and accompaniment therapies. Sound, musical and music are the means used to support, maintain or improve a person's physical and mental health.

The patients involved in the study are patients cared at the ICM for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

The aim is to assess the impact of music therapy on the pain of these patients. The patient is proposed to participate in a music therapy session. Before this session, the music therapist will assess the pain and the presence of symptoms with the patient.

Following this exchange, she will define the device best suited to his expectations and his needs and will propose his a relaxation session induced by music.

After the session the music therapist will assess with the patient the pain and the presence of symptoms.

The patient's feelings and satisfaction about this music therapy session as well as his possible wish to participate in another session will also be evaluated.

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Crossover
Time Perspective:
Prospective
Official Title:
Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer
Actual Study Start Date :
May 2, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Evaluation of the impact of music therapy on the pain of patients

One music therapy session

Other: one music therapy session
Edmonton Symptom Assessment System (ESAS) scale (before and after music therapy session), Numerical pain scale (before and after music therapy session)

Outcome Measures

Primary Outcome Measures

  1. Change between before and after music therapy session on patients pain [at day 1 (before and after the music therapy session)]

    Evolution of pain assessed by a numerical pain scale ranging from 0 to 10 (10 indicating the highest degree of pain)

Secondary Outcome Measures

  1. Description of symptom management [at day 1 (before and after the music therapy session)]

    By the Edmonton Symptom Assessment System scale symptom score. This is a self-assessment scale of the most common symptoms in palliative care:pain, dyspnoea, fatigue, drowsiness, appetite, anxiety, depression, well-being and other possible symptoms. It's a numerical scale ranging from 0 to 10 (with higher scores indicating more severe symptoms). The Edmonton Symptom Assessment System scale allows to: Detect the symptoms present, quantify them and follow their evolution Validate with the patient the symptoms that bother him and that he wishes to be treated as a priority Communicate quickly between the different professionals involved in the treatment.

  2. Patient wishing a second session of music therapy [at day 1 (after the music therapy session)]

    Proportion of Patient wishing a second session of music therapy

  3. Patient satisfaction of the music therapy session [at day 1 (after the music therapy session)]

    Assessment of the satisfaction of the music therapy session. Assessment made by a numerical scale ranging from 0 to 10 (10 indicating high satisfaction)

  4. Agreement to participate in the study [at inclusion]

    Proportion of patients agreeing to participate among the eligible patients to whom the study was proposed

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male/female over 18 years old

  • Patient cared for at the ICM for advanced cancer followed by the Mobile Palliative and/or Pain Care Team

  • Patient with pain score >= 3 (cancer related)

  • Patient who accepts a music therapy session

  • Patient having expressed his oral non-opposition

  • Patient able to communicate

  • Patient affiliated to the French Social Security System.

Exclusion Criteria:
  • Patient with uncorrected hearing loss to normal

  • Patient under guardianship, curatorship or safeguard of justice

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institut du Cancer de Montpellier Montpellier France 34298

Sponsors and Collaborators

  • Institut du Cancer de Montpellier - Val d'Aurelle

Investigators

  • Study Chair: Caroline GALLAY, Institut du Cancer de Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Institut du Cancer de Montpellier - Val d'Aurelle
ClinicalTrials.gov Identifier:
NCT05315427
Other Study ID Numbers:
  • PROICM 2021-10 OMS
  • 2021-A02020-41
First Posted:
Apr 7, 2022
Last Update Posted:
Jun 13, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institut du Cancer de Montpellier - Val d'Aurelle
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 13, 2022